Vitamin D Market

SKU: DMFB2445 | Last Updated On: Sep 28 2022 | Available Formats

> Global Vitamin D Market Expected to reach a high CAGR of 7.2% By 2029: DataM Intelligence

Vitamin D Market is segmented By Analog (Vitamin D3, Vitamin D2), By Strength (500,000 IU, 100,000IU, 40MIU, Others), By Form (Dry, Liquid), By Application (Feed & pet Food, Animal Feed, Pet Food, Pharmaceuticals, Functional Food & beverages, Personal Care), By End-Users (Adults, Pregnant Women, Children, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029

Vitamin D Market is predicted to reach a high CAGR of 7.2% during the forecast period (2022-2029). Vitamin D is a fat-soluble vitamin that is synthesised in the body when UV radiation from the sun impact the skin and cause vitamin D production. It's only found in a few foods naturally. It's also used as a nutritional supplement. Vitamin D aids in the absorption of calcium in the intestine.

Market Dynamics:

One of the key factors driving the growth of the vitamin D market is the prevalence of vitamin D deficiency in various nations. Vitamin D insufficiency is estimated to affect 8% of Americans, according to the Centers for Disease Control and Prevention (CDC). Vitamin D deficiency leads to rickets in children and osteoporosis in adults. It's also linked to common malignancies, high blood pressure, and viral illnesses. Vitamin D is required for the development of skeletal structure and dental enamel in children. Vitamin D deficiency in newborns can lead to problems including development failure, irritability, rickets, and a higher risk of respiratory infections later in life.

A key driver driving the Vitamin D Ingredients market during the projected period is the rising demand for vitamin D ingredients in the cosmetic industry. For example, vitamin D's most significant practical application in the skin is as a mild-to-moderate anti-inflammatory used therapeutically as a cream in the treatment of diseases including psoriasis, eczema, and vitiligo. As a result of the rising number of individuals suffering from psoriasis and eczema, creams containing vitamin D are becoming more popular, driving up demand for Vitamin D Ingredients in the future.

COVID-19 Impact:

Vitamin D is important not only for improving the human innate immune system but also for preventing it from becoming dangerously hyperactive. As a result, having enough vitamin D levels protects the patient against serious problems, including death, caused by Covid-19. As a result, the global need for vitamin D is projected to skyrocket as a result of the Covid-19 epidemic. Disruption of global logistics and supply chains, on the other hand, might be a stumbling block for this sector.

Vitamin D Market Scope



Market CAGR


Segments Covered

By Analog, By Strength, By Form, By Application, By End-Users, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

Market Segmentation:

The global vitamin D market is segmented based on the analog such as vitamin D3 and vitamin D2. Vitamin D3 was the leading analogue on the market for vitamin D. Vitamin D3 is an important vitamin needed for bone health and osteoporosis and rickets aversion. Vitamin D3 has various roles and is used in the food, feed and healthcare industries. Excessive use of vitamin D3 has been linked to toxicity, thus its usage in the food and beverage sector is strictly regulated to avoid the risk of an overdose.

Vitamin D2 is used for the prevention of rickets among children. Vitamin D2 is also recommended for the treatment of osteomalacia, hypoparathyroidism, and hypophosphatemia. During the projected period, the D2 vitamin category is expected to increase at a CAGR of over 7.2%. Due to the growing demand for natural and herbal-based components, vendors are advised to base their product formulations on natural sources. In health-conscious countries, this is a key growth strategy. Vitamin D2 is widely used in the dietary supplement market, with the majority of consumers being babies and children having a 25 (OH)D level of less than 20ng/mL.

Further, the market is also classified based on the form as dry and liquid. The majority of the market is made up of dry vitamin D, which is more stable and has a longer shelf life. Vitamin D3, which is the most popular product, is widely produced in dry powder form for use as a premix in feed production and in nutritional supplements. The rise of the dry form has been aided by advancements in production processes, such as the spray dry technique, and a demand for extended shelf life. In end-user sectors such as medicines, feed, and cosmetics, beadlet and crystalline forms, which are seen as emerging perspective forms, are chosen.

Geographical Penetration:

By region, the global vitamin D market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. In 2020, North America held a 26% market share, with the United States contributing the most. Around 42% of people in the United States are vitamin D deficient. Increased health among the millennial generation, a high proportion of vitamin D-fortified dietary supplements, obligatory vitamin D fortification laws, and pharmaceutical industry investments are all key growth drivers for the market. Because of its importance in boosting immunity, COVID-19 has raised the demand for vitamin D supplements in the region.

China and India were the APAC region's top contributors, accounting for nearly 51% of the region's income in 2020. During the projection period, the market is projected to be driven by rapid urbanisation, changes in lifestyle, western influence in food consumption, demographic profile, and attractive possibilities for industrial investments and expansions. The feed and pharmaceutical sectors are anticipated to generate the greatest growth in the APAC region, with a CAGR of XX% during the projection period. The rising frequency of osteoporosis among Japanese people is also boosting the demand for vitamin D supplements.

Competitive Landscape:

The global vitamin D market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Koninklijke DSM N.V, Zhejiang Garden Biochemical High-Tech Co., Ltd, Zhejiang Xinhecheng Co., Ltd., Fermenta Biotech Ltd., Xiamen Jindawei Vitamin Co., Ltd., Basf, Taizhou Haisheng Pharmaceutical Co., Ltd., and Zhejiang Medicine Co., Ltd. are the leading market players with significant market share. The major players are using product development, novel product launches, market expansion, capacity utilization, and product diversification strategies for holding their position in the market. The companies are entering into collaborations, mergers, strategic partnerships, and acquisitions to increase the demand for vitamin D and their expansion across the globe.

  • For instance, in January 2019, Zhejiang Xinhecheng Co., Ltd. had entered into an agreement with DSM for the sale and purchase of cholesterol. Cholesterol is used to produce vitamin D3. This agreement would help the company to increase its overall capacity and productivity of Vitamin D.
  • Fermenta Biotech Limited (India) secured a 99-year lease with the Gujarat Industrial Development Corporation (GIDC) authority in January 2019 to purchase about 40000 square meters of land for future growth.
  • The FDA authorised an increase in the intake of Vitamin D as an optional additive in milk in January 2018. Soy drinks, coconut drinks, and edible veggie yoghurt all include it. Manufacturers may now add components to a variety of meals thanks to this permission.

Pfizer Inc


Pfizer Inc. (Pfizer) is a worldwide biopharmaceutical business with a strong scientific foundation. The business of the company is biopharmaceutical product research, manufacturing, marketing, sales, and distribution. Medicines and vaccines are part of its global portfolio. In order to create health, prevention, treatments, and cures, the company works across markets. In order to assist and offer access to healthcare, it works with healthcare professionals, governments, and local communities.

Product Portfolio:

  • Caltrate 600+D3 minerals
  • Caltrate 600+D3 plus minerals chewable
  • Caltrate 600+D3 plus minerals minis

Key Developments:

  • In 2021, pfizer acquires Amplyx Pharmaceuticals and its anti fungal compound Fosmanogepix. This deal expands its products for anti-infective
  • In June 2019, Pfizer and Array BioPharma announced their final merger. Pfizer's future revenue is projected to be considerably boosted by Array's extensive pipeline of targeted cancer therapies in development, as well as its portfolio of potentially best- and first-in-class medicines.

Trending Topics

APAC & MEA Pet Food Market

Animal Feed Micronutrients Market

Pet Food Ingredients Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!